Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Sold by Clearbridge Investments LLC

Clearbridge Investments LLC trimmed its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRGFree Report) by 21.0% during the fourth quarter, according to its most recent Form 13F filing with the SEC. The firm owned 1,543,919 shares of the medical equipment provider’s stock after selling 410,477 shares during the period. Clearbridge Investments LLC owned about 0.43% of Intuitive Surgical worth $805,864,000 at the end of the most recent reporting period.

Other institutional investors also recently added to or reduced their stakes in the company. M.E. Allison & CO. Inc. purchased a new stake in shares of Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd purchased a new stake in Intuitive Surgical during the 4th quarter worth about $82,517,000. Sycomore Asset Management boosted its position in shares of Intuitive Surgical by 27.4% during the 4th quarter. Sycomore Asset Management now owns 18,945 shares of the medical equipment provider’s stock worth $9,214,000 after acquiring an additional 4,079 shares in the last quarter. Exome Asset Management LLC increased its holdings in shares of Intuitive Surgical by 16.8% in the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock valued at $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, China Universal Asset Management Co. Ltd. raised its position in shares of Intuitive Surgical by 5.6% during the 4th quarter. China Universal Asset Management Co. Ltd. now owns 9,843 shares of the medical equipment provider’s stock worth $5,138,000 after acquiring an additional 525 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Analysts Set New Price Targets

Several brokerages have commented on ISRG. CICC Research started coverage on shares of Intuitive Surgical in a research note on Monday, January 27th. They issued a “neutral” rating and a $550.00 price target on the stock. Bernstein Bank increased their target price on shares of Intuitive Surgical from $655.00 to $700.00 and gave the company an “overweight” rating in a research report on Monday, January 27th. Jefferies Financial Group boosted their price target on shares of Intuitive Surgical from $475.00 to $575.00 in a research report on Monday, January 27th. Raymond James raised their price objective on Intuitive Surgical from $560.00 to $688.00 and gave the stock an “outperform” rating in a report on Friday, January 24th. Finally, Evercore ISI upped their target price on Intuitive Surgical from $490.00 to $530.00 in a research report on Monday, January 27th. One investment analyst has rated the stock with a sell rating, five have issued a hold rating and fifteen have issued a buy rating to the stock. Based on data from MarketBeat, Intuitive Surgical currently has a consensus rating of “Moderate Buy” and a consensus price target of $611.86.

Read Our Latest Stock Report on Intuitive Surgical

Insider Activity at Intuitive Surgical

In related news, VP Fredrik Widman sold 810 shares of the company’s stock in a transaction that occurred on Monday, March 3rd. The stock was sold at an average price of $573.78, for a total value of $464,761.80. Following the sale, the vice president now owns 473 shares of the company’s stock, valued at approximately $271,397.94. This represents a 63.13 % decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, CFO Jamie Samath sold 94 shares of the stock in a transaction on Wednesday, January 29th. The shares were sold at an average price of $571.11, for a total value of $53,684.34. Following the sale, the chief financial officer now directly owns 2,630 shares in the company, valued at approximately $1,502,019.30. The trade was a 3.45 % decrease in their position. The disclosure for this sale can be found here. Insiders sold 33,754 shares of company stock valued at $17,691,621 in the last ninety days. Corporate insiders own 0.70% of the company’s stock.

Intuitive Surgical Trading Down 3.2 %

ISRG stock opened at $491.84 on Friday. The company’s 50-day moving average price is $556.28 and its 200 day moving average price is $532.68. Intuitive Surgical, Inc. has a 52 week low of $364.17 and a 52 week high of $616.00. The company has a market cap of $175.18 billion, a P/E ratio of 76.73, a P/E/G ratio of 5.85 and a beta of 1.43.

About Intuitive Surgical

(Free Report)

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

See Also

Institutional Ownership by Quarter for Intuitive Surgical (NASDAQ:ISRG)

Receive News & Ratings for Intuitive Surgical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Intuitive Surgical and related companies with MarketBeat.com's FREE daily email newsletter.